Stay updated with breaking news from Brain Stimulation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FDA 510(k) clearance will expand the reach of Rune Labs' precision neurology platform to millions of people with or at risk of developing Parkinso...
Dublin, May 31, 2022 (GLOBE NEWSWIRE) -- The "Global Deep Brain Stimulation Growth Opportunities" report has been added to ResearchAndMarkets.com's...
/PRNewswire/ -- According to the study undertaken by Astute Analytica, the Global Neurostimulation Device Market is forecasted to witness a rise in its revenue...
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra of the midbrain and basal ganglia, followed by dopamine deficiency in the brain. Dopamine plays a crucial role in motor coordination, memory, and cognition; its decrease in PD leads to dyskinesia, cognitive deficits, and depression. In addition, the formation of alpha-synuclein protein aggregates (Lewy bodies) causes further damage to the CNS. Current treatment options include dopamine precursors, inhibitors of dopamine metabolism, upregulation of autophagy, ad...
People with Parkinson's disease and their doctors confront many unknowns, including the answer to exactly how deep brain stimulation (DBS) relieves some of the motor symptoms patients experience.